Here are some completed Know AML 🔴⚫️ word searches ✍🏻 how are you getting on?? Can you beat the time of 14 mins?! #KnowAML 🔴⚫️ #WorldAMLDay #AML

VICTOR will enable patients to access an alternative, less intensive treatment for #AML. We hope this exciting study can reduce side effects vs. standard chemotherapy and even enable treatment at home (thread) #WorldAMLDay Know AML 🔴⚫️ Cure Leukaemia Richard Dillon

Hayley joined CCH_Bham at the height of the #COVID19 pandemic and has been working on vital #ClinicalTrials, including OCTAVE, which aims to evaluate how the body reacts to COVID19, following vaccination, in clinically vulnerable groups (thread) #nursesday2021

🚨 New research (part 1) 🚨 Reducing the need for chemotherapy in people with acute myeloid leukaemia (AML) 👨‍🔬 In this project Richard Dillon at King's Faculty of Life Sciences & Medicine will look for markers in DNA that will tell clinicians if people with AML are likely respond to a drug called venetoclax

bloodcancer.org.uk/research/resea…

Because our supporters were determined to keep donating & fundraising through the pandemic we were able to fund £2m of new research last month including Richard Dillon's team investigating if #AML can be treated without chemotherapy. #amazing 👇 bloodcancer.org.uk/research/resea…

RECOVERY Pre-print: In patients hospitalised with COVID-19 but no natural antibody response, monoclonal antibody infusion: - reduced mortality - increased speed of discharge - reduced progression to invasive mechanical ventilation or death medrxiv.org/content/10.110…

Had to wait for a long train ride to fully listen to this truly unmissable interview One great quote, among many: “The biggest tragedy is not that our drugs don’t work very well - though that’s a tragedy. The biggest tragedy is that we don’t know who they’re gonna work in.”

We would like to thank all the speakers who joined us for a serie of seminars : tobiasmenne Anita Kienesberger Moshe Mittelman EMMANOUIL NIKOLOUSIS Prof. Amit Patel 🇬🇧 Richard Dillon - All recordings are now available here: acuteleuk.org/upcoming-semin…

First patient recruited into Victor study Cardiff and Vale University Health Board Richard Dillon @Tap_Clin_Trials , fantastic support again from the study team 👍👍

Clinical impact of NPM1-mutant molecular persistence after chemotherapy for acute myeloid leukemia - Further results from the UK NCRI AML17 trial in collaboration with Australian colleagues. Hope you enjoy :-) sciencedirect.com/science/articl…

Understanding the design of phase 3 trials in oncology 2000 2022

Ultra sensitive detection of FLT3-ITD: a novel and powerful MRD marker - and one that could potentially be used to guide molecularly targeted interventions. Read all about it here! ashpublications.org/blood/article/…

Off to do some filming about what we can do RIGHT NOW to bring forward the day when no one dies of their blood cancer. King's College London & Guy's and St Thomas' the location which is very apt given the vital role they both play in cancer discovery and treatment.

Have turned ⁦Richard Dillon⁩’s office into a green room while he’s away - nice view Richard! Miss you!

Took over Richard Dillon’s lab for the morning to do something fun! Thanks for having us ☺️ Laurencio 🎆 Gemma Peters

Congratulations to our REBEL alliance Will Villiers, Bori Mifsud, Richard Dillon, Halima Bensmail, Abdurrahman Elbasir and our non-Twittered colleagues for an excellent collaboration.

Congratulations to Will Villiers on his first born paper, i'm sure its the first of many.

Dream Job Opportunity ! Academic Clinical Fellowship in Haematology (Guy's, King's, UCLH and Barts available) please contact me if interested in the Guy's / Kings one. oriel.nhs.uk/Web/PermaLink/…

Read the review by Brunangelo Falini and Richard Dillon. Criteria for diagnosis and molecular monitoring of #NPM1-mutated #AML. bit.ly/3QSHni9 Università degli Studi di Perugia King's Faculty of Life Sciences & Medicine #acutemyeloidleukemia #leusm